肾癌伴腔静脉癌栓的双途径血管造影诊断与介入治疗  

Double routes angiographic diagnosis and interventional therapy for renal cell carcinoma with IVC tumor emboli

作　　者：单鸿[1,2] 陈卫国[1,2] 姜在波[1,2] 李彦豪 关守海[1,2] 黄明声[1,2] 

机构地区：[1]中山医科大学附属第三医院放射科 [2]第一军医大学南方医院放射科

出　　处：《中华放射学杂志》1998年第5期300-302,共3页Chinese Journal of Radiology

摘　　要：目的评价经肾动脉和下腔静脉双途径对肾癌伴下腔静脉癌栓的诊断与介入治疗的价值。方法在２８例肾癌血管造影与介入治疗材料中，分成以介入治疗为主组１６例，和以介入性术前化疗栓塞为辅组１２例两组，重点对以介入治疗为主的１６例中６例提示伴腔静脉癌栓的患者进行分析。结果经肾动脉途径对肾癌伴腔静脉癌栓的显示率在２８例中仅检出１例，占４％，腔静脉造影对其癌栓的显示则明显提高。１６例介入治疗组的１年和２年生存率分别为８１％与３１％。结论经肾动脉和腔静脉双途径血管造影对肾癌特别是伴腔静脉癌栓的术前诊断具有重要意义。Purpose To evaluate the values of diagnosis and treatment of transrenal artery and trans inferior vena cava (IVC) for renal cell carcinoma (RCC) with IVC tumor emboli. Methods 28 patients with RCC were divided into two groups: interventional treatment(16 patients) and surgical treatment with additional transrenal artery chemo-embolization (TRCE)(12). Special analysis was made on 6 patients with IVC tumor emboli. Results The demonstration rate of transrenal arteriography to IVC tumor emboli was 4% in the 28 patients. IVC venography could raise this rate. 1 year and 2 year survival rates of the 16 patients recieved interventional therapy were 81% and 31% respectively. Conclusion Double routes angiography play significant roles in angiographic diagnosis of RCC, especially in RCC with IVC tumor emboli. Transcatheter IVC thrombolytic chemotherapy is an important palliative treatment.

关 键 词：肾肿瘤 肿瘤循环细胞 血管造影术 介入放射学 

分 类 号：R737.11[医药卫生—肿瘤]